Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
09/01/2026 12:34
Jan 9 (Reuters) - Beta Drugs Ltd BTAD.NS: TO BUY 66.09% OF EQUITY SHARE CAPITAL IN NIVIAN LIFE SCIENCES FOR 694 MILLION RUPEES Further company coverage: BTAD.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beta Drugs
See all newsBrief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution